Story of the week – The FDA Approved a Dengue Fever Vaccine—Here’s What You Need to Know

3 May, 2019
, Source:

By Maggie O’Neill 

The FDA approved a vaccine for dengue virus, which causes dengue fever, it said yesterday in a statement. The vaccine, called Dengvaxia, was previously approved in the European Union and 19 other countries.

You don’t need to worry about getting the vaccine before you go on a vacation unless you’ve already had dengue disease in the past. “The first infection with dengue virus typically results in either no symptoms or a mild illness that can be mistaken for the flu or another viral infection. A subsequent infection can lead to severe dengue, including dengue hemorrhagic fever (DHF), a more severe form of the disease that can be fatal,” the statement explains.

If you think you’ve had dengue virus in the past but aren’t sure, a blood test can confirm it for you. So if you frequent tropical locations and you’re pretty sure you had dengue disease as a kid, it might be worth your while to talk to your doctor about getting Dengvaxia. After the initial dose of the vaccine, you need to get a second dose 6 months later, then a third another 6 months after that.  Read full article


This entry was posted on Friday, May 3rd, 2019 at 6:21 pm and is filed under Blog.

Literature Literature archive

S Krishnaswamy, P Lambach, ML Giles 2019 HUMAN VACCINES & IMMUNOTHERAPEUTICS VOL. 15, NO. 4, 942–950
Editorial 2019 Lancet Adolescent Health Vol 3: 281
AHviid, JVinsløv Hansen, M Frisch,, et al 2019 Ann Intern Med 170(8):513-520.

Videos Video archive

VCP Research Fellow Emilie Karafillakis comments on the anti-vaccination movement, the role of social media and the importance of rebuilding trust. 

In this video Prof Larson explains what vaccine confidence is, the team’s work, and what needs to be done to restore vaccine confidence around the world.

As part of the LSHTM Vaccine Centre podcast series to celebrate World Immunization Week Prof Heidi Larson recorded an episode with about her work and the VCP.

Subscribe to our mailing list

Click here to go to our GDPR-compliant signup form.

The Vaccine Knowledge Project at the Oxford Vaccine Group